J Biol Chem, Vol. 274, Issue 44, 31632-31640, October 29, 1999
Carboxypeptidase M, a Glycosylphosphatidylinositol-anchored
Protein, Is Localized on Both the Apical and Basolateral Domains of
Polarized Madin-Darby Canine Kidney Cells*
Gerd B.
McGwire
§,
Robert P.
Becker¶, and
Randal A.
Skidgel
§
**
From the
Laboratory of Peptide Research and the
Departments of § Pharmacology,
Anesthesiology, and
¶ Anatomy and Cell Biology, University of Illinois College of
Medicine, Chicago, Illinois 60612
 |
ABSTRACT |
Carboxypeptidase M, a
glycosylphosphatidylinositol-anchored membrane glycoprotein, is highly
expressed in Madin-Darby canine kidney (MDCK) cells, where it was
previously shown that the glycosylphosphatidylinositol anchor and
N-linked carbohydrate are apical targeting signals. Here,
we show that carboxypeptidase M has an unusual, non-polarized distribution, with up to 44% on the basolateral domain of polarized MDCK cells grown on semipermeable inserts. Alkaline phosphatase, as
well as five other glycosylphosphatidylinositol-anchored proteins, and
transmembrane
-glutamyl transpeptidase exhibited the expected apical
localization. Basolateral carboxypeptidase M was readily released by
exogenous phosphatidylinositol-specific phospholipase C, showing it is
glycosylphosphatidylinositol-anchored, whereas apical carboxypeptidase
M was more resistant to release. In contrast, the spontaneous release
of carboxypeptidase M into the medium was much higher on the apical
than the basolateral domain. In pulse-chase studies, newly synthesized
carboxypeptidase M arrived in equal amounts within 30 min on both
domains, indicating direct sorting. After 4-8 h of chase, the
steady-state distribution was attained, possibly due to transcytosis
from the basolateral to the apical domain. These data suggest the
presence of a unique basolateral targeting signal in carboxypeptidase M
that competes with its apical targeting signals, resulting in a
non-polarized distribution in MDCK cells.
 |
INTRODUCTION |
Regulatory B-type carboxypeptidases play important roles by
specifically cleaving C-terminal Arg or Lys residues from peptides and
proteins (1). Carboxypeptidase M
(CPM),1 a member of this
family of enzymes, is a glycosylphosphatidylinositol (GPI)-anchored
plasma membrane enzyme, widely distributed in human tissues (1-5) and
often highly expressed in epithelial cells (1, 5), including
Madin-Darby canine kidney (MDCK) cells (6). The MDCK cell line is
speculated to have originated from distal renal tubular epithelial
cells (7, 8) and has been used extensively as a model of polarized
renal tubular epithelium. These cells were also used to show that all
GPI-anchored surface proteins are specifically localized to the apical
surface (9). Additional studies on the sorting of GPI-anchored proteins
revealed their apical localization to be a conserved feature of
polarized epithelial cells from other tissues and species (10). These data, together with studies using genetically engineered GPI fusion proteins (11, 12), resulted in the classification of the GPI anchor as
a dominant apical sorting signal (13, 14). More recently, the MDCK cell
line was used as a model system to show that N-linked
carbohydrate is an additional apical targeting signal (13, 15).
CPM activity and mRNA are found in human kidney (5, 16), which also
secretes CPM into urine (17, 18). Although the roles of CPM in kidney
function have not been clearly defined, erythropoietin, bradykinin, and
epidermal growth factor (EGF) are potential CPM substrates that are
generated in the kidney and excreted into urine. Kinetic studies with
bradykinin (19) and EGF (17) showed that these peptides are good
substrates of CPM in vitro. Bradykinin induces natriuresis,
diuresis, and prostaglandin synthesis in the kidney; thus, inactivation
by CPM could play a role in the regulation of salt and water balance (1, 20). The biological role of CPM in renal tubular epithelium will
depend on its apical or basolateral localization because its endogenous
peptide substrates and corresponding receptors can also have polarized
distributions. For example, CPM is responsible for the initial
metabolism of EGF to des-Arg53-EGF at the surface of MDCK
cells (17). Because the EGF receptor is predominantly expressed on the
basolateral domain of these cells (21), the functioning of CPM in this
pathway would be possible only if it was expressed on the same domain.
CPM was positively identified on the apical surface of MDCK cells (6), but a possible basolateral localization could not be determined because
of the inaccessibility of the antibodies to this surface in the
techniques that were employed. However, the fact that CPM is both
GPI-anchored and N-glycosylated would argue against a substantial basolateral distribution. In this study, the cell-surface distribution and sorting of CPM were investigated. We show that CPM is
present on both the apical and basolateral domains of MDCK cells, in
contrast to the apical localization reported for other GPI-anchored proteins.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Fetal bovine serum (FBS) was from Atlanta
Biologicals, Inc. Dulbecco's modified Eagle's medium (DMEM), Ham's
nutrient mixture F-12, Hanks' balanced salt solution (HBSS),
phosphate-buffered saline (PBS), reduced glutathione, iodoacetamide,
Triton X-100, and Triton X-114 were from Sigma.
Sulfo-N-hydroxysuccinimido-LC-biotin (sulfo-NHS-LC-biotin) and sulfo-NHS-SS-biotin were from Pierce. Immobilized streptavidin was from Roche Molecular Biochemicals. 5-Dimethylaminonaphthalene-1-sulfonyl-L-alanyl-L-arginine
(dansyl-Ala-Arg) was synthesized and purified as described (22). The
ProLong anti-fade kit and fluorescein isothiocyanate-conjugated goat
anti-rabbit Alexa 488 were from Molecular Probes, Inc. (Eugene, OR).
Redivue Pro-mix L-[35S] in vitro
labeling mixture was from Amersham Pharmacia Biotech. Phosphatidylinositol-specific phospholipase C (PI-PLC) from
Bacillus thuringiensis was from ICN or Oxford Glycosystems.
Most other chemicals were from Fisher.
Cells and Cell Culture--
MDCK cells (CCL-34) were obtained
from the American Type Culture Collection (Manassas, VA). Cells were
cultured in DMEM containing 4.7 g/liter sodium bicarbonate, 25 mM Hepes, 100 units/liter penicillin, 0.1 mg/ml
streptomycin, and 10% heat-inactivated FBS.
Determination of Enzyme Activity--
CPM activity was
determined in a fluorometric assay with dansyl-Ala-Arg as the substrate
as previously published (22, 23).
For measurement of CPM activity in intact monolayers, cells were rinsed
with HBSS containing 4.7 g/liter sodium bicarbonate, 25 mM
Hepes, 100 units/liter penicillin, and 0.1 mg/ml streptomycin (HBSS-BH). Buffer containing 0.2 mM dansyl-Ala-Arg was
added apically or basolaterally to 12-mm (0.5 ml) or 24.5-mm (1 ml)
inserts. An equal amount of buffer without dansyl-Ala-Arg was added to the opposite, control side. Cells were incubated at 37 °C in 5% CO2 for 0.5-1 h, and then 250 µl of buffer was collected
from each side and added to 150 µl of 1 M citric acid.
The product was extracted, and the fluorescence was measured as
described (22, 23).
Alkaline phosphatase was measured in a colorimetric end-point assay
using a kit (Sigma) as described by the manufacturer, except that the
reaction was scaled down to use 25 µl of sample in a total reaction
volume of 275 µl.
-Glutamyl transpeptidase was measured in a
colorimetric end-point assay with
-glutamyl-p-nitroanilide as the substrate essentially as
described (24, 25).
Determination of Protein Concentration--
Protein
concentrations were measured as described (26) using BSA as the standard.
Verification of MDCK Cell Monolayer Integrity--
MDCK cells
(5 × 104 or 2.5 × 105 cells) were
seeded into 12- or 24.5-mm Transwell cell culture inserts,
respectively, and grown for 5-7 days, after which experiments were
performed. The integrity and tightness of the MDCK monolayers were
routinely determined by transepithelial electrical resistance and
occasionally by [3H]methoxyinulin (5000 Da) diffusion.
Cells used for experiments had a transepithelial electrical resistance
of >400 ohms·cm2 and an apical-to-basolateral
[3H]methoxyinulin (1 µCi/ml) diffusion of <2%.
Domain-selective Biotinylation--
Cell monolayers in 24.5-mm
inserts were biotinylated apically or basolaterally as described (9)
with some modifications. All treatments were performed on ice. Cells
were washed five times with ice-cold PBS containing 0.1 mM
CaCl2 and 1 mM MgCl2 (PBS-CM), and
1 ml of sulfo-NHS-LC-biotin (0.5 mg/ml) in PBS-CM was added to one or
both sides of the inserts. Buffer alone was added to the opposite side
when biotinylation was performed on only one side. Cells were incubated
for 20 min, after which the solution was removed, fresh biotin solution
was added, and the incubation was repeated. Free biotin was quenched by
washing the cells three times for 2 min each with serum-free DMEM
containing 50 mM NH4Cl.
Streptavidin Precipitation--
Membranes containing
biotinylated cell monolayers were excised, and the cells were
solubilized in 20 mM potassium phosphate buffer, pH 7.5, containing 0.15 M NaCl, 1% Triton X-100, and 60 mM n-octyl glucoside for 2-12 h at 4 °C with
rotation. The filters were removed, and insoluble material was removed
by a 1-h centrifugation at 100,000 × g. An either
equal or double volume of immobilized streptavidin slurry (50%) was
added to the lysates, and the mixture was incubated at 4 °C
overnight. The streptavidin was removed by a 10-min centrifugation in a
microcentrifuge, and CPM,
-glutamyl transpeptidase, and alkaline
phosphatase activities were measured in the supernatant. Activities in
samples were compared with controls treated identically except for
omission of the biotinylation reagent. The amount of each enzyme on the
apical and basolateral domains was taken as the amount of activity
precipitated by streptavidin following apical and basolateral
biotinylation, respectively.
Identification of Biotinylated CPM by Immunoprecipitation,
SDS-PAGE, and Electroblotting--
Membranes containing biotinylated
cell monolayers were excised, and the cells were solubilized in 1 ml of
cell lysis buffer (25 mM Tris-HCl, pH 7.5, containing 0.1 M NaCl, 2.5% Triton X-100, 60 mM
n-octyl glucoside, 5 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 0.1 mM leupeptin, 1 µM pepstatin A, and 10 µM E-64
(trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane)) for 1 h at 4 °C with rotation. The filters were removed, and
insoluble matter was removed by a 5-min centrifugation in a
microcentrifuge. The lysates were preadsorbed with 10 µl of normal
rabbit serum (1:2 diluted) followed by 50 µl of a 1:3 protein
A-Sepharose slurry. The precipitates were pelleted, and the
supernatants were transferred to new tubes. CPM was immunoprecipitated
by incubation overnight at 4 °C with 20 µl of polyclonal rabbit
anti-human CPM antibody, purified as described (5), followed by protein
A-Sepharose precipitation. The precipitates were washed four times with
mixed micelle buffer (25 mM Tris-HCl, pH 8.0, containing
0.15 mM NaCl, 5 mM EDTA, 8% sucrose, 1%
Triton X-100, 0.2% SDS, and 0.2 mM phenylmethylsulfonyl fluoride) and then once with the same buffer without detergents. Bound
protein was eluted in Laemmli buffer containing 0.1% dithiothreitol and resolved by SDS-PAGE (8% gel). Proteins were electroblotted onto
Immobilon-P and detected with streptavidin-horseradish peroxidase followed by chemiluminescence using an ECL kit (Amersham Pharmacia Biotech).
Immunofluorescence Microscopy--
Cells were grown for 5 days
on 6.25-mm diameter Falcon P.E.T. membrane cell culture inserts. The
cells were rinsed twice with HBSS-BH and then fixed in 1% formaldehyde
(depolymerized from paraformaldehyde) in the same buffer. The cells
were rinsed 3 × 5 min with 0.1 M glycine in HBSS-BH
and then 3 × 10 min with HBSS-BH, followed by preincubation in
HBSS-BH containing 0.2% BSA and 5% normal goat serum for 30 min.
Purified rabbit anti-human CPM antiserum (5) was diluted 1:20 (final
protein concentration = 5 µg/ml) in HBSS-BH containing 0.2%
BSA, 5% normal goat serum, and 0.01% sodium azide and was then added
to both sides of the insert. The cells were incubated for 36 h at
4 °C, when the antibody was removed, and the cells were washed
3 × 10 min with HBSS-BH. The cells were then again preincubated
in HBSS-BH containing 0.2% BSA, 5% normal goat serum, and 0.01%
sodium azide for 30 min, followed by a 2-h incubation with fluorescein
isothiocyanate-conjugated goat anti-rabbit secondary antibody diluted
1:300 in the same buffer (6.67 µg/ml final concentration) and added
to the apical and basolateral sides. The cells were finally washed
3 × 10 min with HBSS-BH and mounted using the ProLong anti-fade
mounting medium for Alexa dyes. The fluorescent staining was evaluated on a Zeiss 510 laser scanning confocal microscope.
Release of CPM by PI-PLC--
Confluent monolayers in 12-mm
inserts were rinsed three times with HBSS-BH. Then, 0.5 ml of the same
buffer, containing various concentrations of PI-PLC (0.002-0.5
units/ml) and 0.1% heat-inactivated BSA (56 °C for 30 min), was
added to the apical or basolateral side of the inserts; and buffer
without PI-PLC was added to the opposite side. After incubation for
4 h at 37 °C, the buffer was collected; any cells were removed
by a 10-min centrifugation in a microcentrifuge; and the released CPM
activity was determined in the supernatant. The basal spontaneous
release of CPM was measured in control cells treated identically except
that buffer without PI-PLC was added instead.
To measure the release of CPM by PI-PLC from membrane fractions, cells
were rinsed with PBS; scraped off; pelleted; resuspended in
fractionation buffer (50 mM Hepes, pH 7.5, and 0.25 M sucrose) containing 1 mM phenylmethylsulfonyl
fluoride, 0.1 mM leupeptin, 1 µM pepstatin A,
and 10 µM E-64; lysed by sonication for 3 × 10 s; and fractionated by sequential centrifugation as described (4). The
final P3 membrane fraction was washed once, resuspended in
fractionation buffer, and incubated with or without PI-PLC (0.5 units/ml final concentration) at 37 °C for 1 h. One-half of the
volume was removed from each reaction, and the soluble and cell
membrane-bound enzymes were separated by a 1-h centrifugation at
100,000 × g. New PI-PLC (0.5 units/ml; 1.0 unit/ml
final concentration) or buffer was added to the remaining reaction
mixtures; and the incubation was continued for an additional hour,
followed by centrifugation as described above. CPM and alkaline
phosphatase were measured in both the high speed sediments and supernatants.
Plasma Membrane Distribution of GPI-anchored Proteins--
The
surface distribution of GPI-anchored proteins in MDCK cells was
determined by domain-specific biotinylation, Triton X-114 extraction,
and PI-PLC release essentially as described (9). Samples were separated
by SDS-PAGE (7.5% gel) and electroblotted onto Immobilon-P.
Biotinylated proteins were detected by alkaline phosphatase-coupled
streptavidin. Protein bands were quantitated with a Protein Design
Institute scanning densitometer.
Metabolic Labeling--
Confluent monolayers of MDCK cells in
24.5-mm inserts were washed twice with HBSS-BH and then incubated for
30 min in Cys- and Met-deficient DMEM containing 5% dialyzed FBS
(1000-Da cutoff). Cells were metabolically labeled for 30 min in 1 mCi/ml [35S]Met/[35S]Cys in the deficient
medium. The labeling medium was removed, and the cells were washed
twice with complete DMEM containing 10% FBS and then incubated in the
same medium containing a 5× normal concentration of unlabeled Met and
Cys. At the indicated times, the chase medium was removed; the cells
were washed three times with ice-cold PBS-CM; and the apical or
basolateral domains were selectively biotinylated as described above.
The filters were excised, and the cells were solubilized in cell lysis
buffer (1 ml/insert) for 1 h at 4 °C with rotation. The filters
were removed, and insoluble matter was removed by a 5-min
centrifugation in a microcentrifuge. CPM was immunoprecipitated with
specific antiserum and protein A-Sepharose as described above.
Precipitated proteins were eluted by boiling the samples for 5 min in
30 µl of 10% SDS. The supernatants were transferred to new tubes and diluted to 1.25 ml with 10 mM Tris-HCl, pH 7.4, containing
0.15 mM NaCl, 1% Triton X-100, and 1 mM EDTA.
Biotinylated proteins were precipitated with 50 µl of
streptavidin-Sepharose (1:3 slurry) for 1 h at 4 °C. The
precipitates were washed twice with mixed micelle buffer and then once
with the same buffer without detergents. Precipitated protein was
eluted in Laemmli buffer containing 1% dithiothreitol, resolved by
SDS-PAGE (8%), and analyzed by autoradiography using a BioMax
TranScreen-LE intensifying screen (Eastman Kodak Co.).
Endocytosis/Transcytosis--
The endocytosis/transcytosis of
basolateral CPM was investigated by biotinylation with
sulfo-NHS-SS-biotin, which can be released by reduction with
glutathione (27). The basolateral side of confluent MDCK cell
monolayers in 24.5-mm inserts was biotinylated at 4 °C with
sulfo-NHS-SS-biotin using the procedure described above. The cells were
incubated at 37 °C in DMEM containing 10% FBS for various amounts
of time, after which they were put on ice and rinsed once with ice-cold
PBS-CM. Any apical or basolateral surface biotin was then removed by a
30-min incubation with a glutathione-containing solution added to
either the basolateral or apical side (1 ml/insert). The solution
consisted of 50 mM glutathione, 90 mM NaCl, 1 mM MgCl2, and 0.1 mM
CaCl2, to which NaOH (60 mM final
concentration) and FBS (10% final concentration) were added just prior
to use as described (28). Control cells were incubated in buffer
without glutathione. The cells were then rinsed once with PBS-CM, and
free sulfhydryl groups were quenched by rinsing twice with 1 ml of
iodoacetamide (5 mg/ml). Following a final rinse with PBS-CM, the
membranes were excised, and the cells were solubilized in 1 ml of cell
lysis buffer as described above. CPM was immunoprecipitated with
polyclonal antiserum to recombinant human CPM, resolved by SDS-PAGE
(8%) under nonreducing conditions, and electroblotted onto
Immobilon-P. Biotinylated proteins were detected with
streptavidin-horseradish peroxidase (1:1500) and the ECL
chemiluminescence kit.
 |
RESULTS |
Apical and Basolateral Distribution of CPM in MDCK Cells--
When
the CPM activity on the surface of intact MDCK cell monolayers was
measured by the hydrolysis of dansyl-Ala-Arg added to the buffer on
either the apical or basolateral side, the apical and basolateral
domains contained approximately two-thirds and one-third of the
extracellular CPM activity, respectively (Table I). A negligible amount (<2%) of
hydrolyzed substrate was detected on the apical side when
dansyl-Ala-Arg was added to the basolateral side and vice versa (Table
I, Footnote c), indicating that the monolayer was
impermeable to the substrate. The carboxypeptidase activity in MDCK
cell membranes had previously been identified as CPM by means of
enzymatic properties and reactivity with specific antiserum to purified
CPM on Western blots (6). However, it could not be ruled out that
another, minor carboxypeptidase was also present on these cells and if,
expressed solely on one side of the cells, it could affect the
distribution determined for CPM. To exclude this possibility, we
specifically immunoprecipitated CPM activity from either the apical or
basolateral side by first removing either the apical or basolateral
activity with domain-specific biotinylation and streptavidin
precipitation, followed by immunoprecipitation of the activity
remaining in the supernatant with antiserum specific for CPM. More than
95% of the remaining activity on either the apical or basolateral side
was immunoprecipitated by specific anti-CPM antiserum (data not shown),
eliminating the possibility of a significant contribution by another
peptidase to the activity being measured.
The relatively non-polarized distribution of CPM was also assessed by
measuring CPM activity precipitable by streptavidin after
domain-selective biotinylation of the cells. The distribution of CPM
was even less polarized (56% apical and 44% basolateral) in these
experiments (Table I), which may more accurately reflect its true
distribution. This is because cells growing on the plastic wall of the
inserts are excluded when the filters are excised (see "Experimental
Procedures" for details), whereas when substrate is added to each
domain, the cells on the wall contribute to the apical (but not
the basolateral) activity. Similar results were obtained when apically
or basolaterally biotinylated CPM was subjected to SDS-PAGE and
visualized with streptavidin-horseradish peroxidase and
chemiluminescence (Fig. 1).
Quantification of the bands by densitometry showed the apical and
basolateral distribution to be 66 and 34%, respectively (average of
two experiments). The 52-53-kDa protein detected on both domains is
consistent with the previously published molecular mass (54 kDa) of
MDCK cell CPM (6). Combined, these results show that CPM has a
relatively non-polarized distribution in MDCK cells and that there is
no difference in the molecular mass of CPM on the apical or basolateral domain.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 1.
Apical and basolateral surface distribution
of biotinylated CPM. The apical or basolateral side of
filter-grown MDCK cells was selectively biotinylated. The filters were
excised, the cells were solubilized, and CPM was specifically
immunoprecipitated. Precipitated protein was resolved by SDS-PAGE,
blotted onto Immobilon-P, and detected with streptavidin-horseradish
peroxidase followed by chemiluminescence. Duplicates are shown for each
treatment. The positions of molecular mass markers are shown on the
left. K, kilodaltons.
|
|
Immunofluorescent Staining of CPM--
When MDCK cells were
stained for CPM, intense labeling was found at the apical surface of
the epithelium, as reveled by confocal optical sectioning (Fig.
2). The somewhat punctate staining
pattern observed probably reflects clustering of CPM induced by
antibody cross-linking, as has been reported for other GPI-anchored
proteins. The lateral surface was also reactive with anti-CPM antibody, whereas the basal surface was marked to a lesser extent. Occasionally, some cells showed a more intense staining at the basal surface (Fig. 2,
d and e). These data are consistent with the
above studies demonstrating CPM on both the apical and basolateral
domains.

View larger version (173K):
[in this window]
[in a new window]
|
Fig. 2.
Localization of CPM in MDCK cells by
immunofluorescent microscopy. Shown are confocal light microscope
optical sections of the apical (a), mid-level
(b), and basal (c) aspects of an MDCK cell layer
and an orthogonal view (d) of the MDCK cell layer at line
x-x' (e). Note the intense immunoreactivity for CPM at the
apical and lateral cell surfaces (a and b). Basal
surfaces show less intense staining for CPM (c).
Occasionally, the basal aspects of cells are more intensely stained
than the apical aspect (d and e).
Bars = 25 µm (a-c) and 15 µm
(d and e).
|
|
PI-PLC Release of CPM--
Previous studies showed CPM to be
attached to the plasma membrane of MDCK cells by a GPI anchor (6).
However, in these experiments, 28% of the activity in a P3
membrane fraction remained membrane-bound after treatment with 0.03 units/ml PI-PLC for 2 h at 37 °C (6). To rule out incomplete
digestion as the cause, P3 membrane fractions were treated
with higher amounts of PI-PLC. After treatment for 1 h with 0.5 units/ml PI-PLC, 39% of the CPM activity remained in the membrane
fraction, and an additional hour of treatment with new PI-PLC resulted
only in an additional 6% release (average values from two
experiments). As a comparison, a much smaller fraction of GPI-anchored
alkaline phosphatase (13%) was resistant to release by PI-PLC in the
same samples.
In light of these results, the possibility existed that a fraction of
CPM might be attached to membranes by a non-GPI anchor, which
consequently could account for the CPM present on the basolateral side.
However, when intact cell monolayers in inserts were treated with
PI-PLC on the basolateral side, a dose-dependent release of
CPM activity into the basolateral buffer was observed (Fig. 3). There was also a
time-dependent release of CPM from the basolateral surface
by a single concentration of PI-PLC (data not shown). Surprisingly, CPM
on the apical surface was more resistant to release by PI-PLC (Fig. 3).
In contrast, although in control cells treated with only buffer, the
spontaneous release of CPM over 4 h was relatively low, it was
much greater from the apical domain (1.15 ± 0.25 nmol/h/insert, n = 6) than from the basolateral side (0.005 ± 0.008 nmol/h/insert, n = 6). These data
show that basolateral CPM is GPI-anchored and that the spontaneous
release of CPM from MDCK cells, which we previously showed was due to
an endogenous phospholipase (29), comes primarily from the apical
domain.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Dose-dependent release of CPM
from MDCK cells by PI-PLC. The apical or basolateral side of MDCK
cell monolayers was incubated with various doses of PI-PLC for 4 h. Buffer from the treated side was removed and assayed for CPM
activity with dansyl-Ala-Arg substrate. Values are given as the
means ± S.D. (n = 3; error bars
smaller than the symbols are not shown).
|
|
Distribution of Other GPI-anchored Proteins in MDCK Cells--
The
presence of a substantial portion of CPM on the basolateral domain of
MDCK cells stands in contrast to the predominantly apical distribution
of GPI-linked proteins that has been reported (9, 10). To rule out the
possibilities that the non-polarized distribution of CPM was due to
either an aberration in the protein sorting pathway in these cells or
the use of a different technique for determining its distribution, the
cellular distribution of GPI-anchored proteins was investigated
following the same protocol used in previous studies (9). Following
biotinylation, Triton X-114 extraction, and PI-PLC treatment, 10 proteins were detected in these cells of which nine were apparently
GPI-anchored (Fig. 4). Of these, five
were found either exclusively or predominantly on the apical side; one
was exclusively on the basolateral side; and three had a relatively
non-polarized distribution (between 37 and 58% apical and 42 and 63%
basolateral) (Fig. 4 and Table II).
Western analysis of a parallel blot with anti-CPM antiserum revealed
that band 5 is CPM (data not shown). (The slightly higher molecular
mass of 57 kDa calculated for CPM in this experiment was due to the use
of different molecular mass standards.) The distribution of CPM (band
5) calculated by this method (58% apical and 42% basolateral) is
consistent with the results from the other methods used. As additional
controls, the distribution of GPI-anchored alkaline phosphatase as well
as the apical transmembrane-anchored enzyme,
-glutamyl
transpeptidase, was determined by domain-selective biotinylation and
streptavidin precipitation. Both proteins exhibited the expected apical
localization (81-89%) (Table III),
providing further evidence that the protein sorting pathway was not
unusual in these cells. The non-polarized distribution of CPM was
confirmed in the same samples (Table III). Together, these data suggest
that no generalized aberration of the protein sorting pathway exists in
these cells.

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 4.
Identification of the apical and basolateral
distribution of GPI-anchored proteins in MDCK cells. Filter-grown
MDCK cell monolayers were selectively biotinylated on the apical or
basolateral side and solubilized in buffer containing 1% Triton X-114.
GPI-anchored proteins, extracted into the detergent phase, were
digested with PI-PLC (+), followed by extraction into an
aqueous buffer, and finally precipitated with sodium deoxycholate and
trichloroacetic acid. Control samples ( ) were treated identically
except without the addition of PI-PLC. Samples were separated by
SDS-PAGE (7.5%) under reducing conditions and electroblotted onto
Immobilon-P. Biotinylated proteins were detected with
streptavidin-alkaline phosphatase. Numbered bands correspond
to those listed in Table II. The positions of molecular mass markers
are shown on the right. K, kilodaltons.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Densitometric quantitation of GPI-anchored proteins in MDCK cells
Analysis was of the numbered bands labeled in Fig. 4.
|
|
Apical and Basolateral Sorting of Newly Synthesized CPM--
To
determine if the surface distribution of CPM arises from non-polarized
sorting of newly synthesized enzyme, pulse-chase studies were carried
out. Metabolically labeled CPM appeared in approximately equal amounts
at both the apical and basolateral sides of cells within 30 min,
suggesting that CPM is initially sorted directly to both domains (Fig.
5). The total amount of labeled CPM on
the cell surface peaked between 2 and 4 h on both domains and then
slowly declined on the basolateral side and remained stable on the
apical side up to 8 h. Substantial amounts remained on both
domains even after an 8-h chase. A slight enrichment of CPM on the
apical domain was observed over time, with the distribution approximately equaling the steady-state distribution between 4 and
8 h (Fig. 5B).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
Pulse-chase analysis of delivery of newly
synthesized CPM to the apical and basolateral domains. MDCK cell
monolayers in 24-mm inserts were pulse-labeled with 1 mCi/ml
[35S]Met/[35S]Cys for 30 min and then
chased for the times indicated. The monolayers were selectively
biotinylated on the apical (A lanes) or basolateral (B
lanes) side; the inserts were excised; and the cells were
solubilized. CPM was selectively immunoprecipitated and resuspended,
and then biotinylated CPM was reprecipitated with
streptavidin-Sepharose. A, precipitated CPM was
resolved by SDS-PAGE and analyzed by autoradiography using an
intensifying screen. The positions of molecular mass markers are shown
on the left. K, kilodaltons. B, shown
are the results from densitometric quantitation. , apical; ,
basolateral.
|
|
To investigate whether the non-polarized distribution of CPM could be
due to predominant apical sorting, but faster degradation at the apical
surface, the rate of elimination of apically or basolaterally
biotinylated CPM from the cells was determined (Fig. 6). The elimination pattern indicated a
first-order process with approximately equal rates of loss of CPM from
either the apical or basolateral domain. The calculated half-lives of
apical and basolateral CPM were 9.5 and 8.1 h, respectively. Thus,
a difference in the rate of loss of CPM from the two domains does not
explain the unusual distribution of CPM.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Elimination of apical and basolateral surface
CPM from MDCK cells. A, MDCK cell monolayers in 24.5-mm
inserts were selectively biotinylated on the apical (A
lanes) or basolateral (B lanes) side and then chased at
37 °C for the times indicated. The cells were solubilized, and CPM
was selectively immunoprecipitated. Precipitated proteins were resolved
by SDS-PAGE and electroblotted onto Immobilon-P. Biotinylated proteins
were detected by streptavidin-horseradish peroxidase followed by
chemiluminescence. The arrow denotes the CPM band; other
bands were nonspecific. The positions of molecular mass markers are
shown on the left. K, kilodaltons. B, shown are
the results from the densitometric quantitation of A. ,
apical; , basolateral. The inset shows a semilogarithmic
plot of B showing first-order kinetics of loss of CPM from
the cells.
|
|
As the spontaneous release of CPM occurs mainly from the apical domain
(see above), the slow loss of newly synthesized CPM from the
basolateral domain and the maintenance of steady levels of CPM on the
apical domain (Fig. 5B) might be due to transcytosis from
the basolateral to the apical domain, followed by release from the
apical surface. To investigate this possibility, basolateral CPM was
labeled with biotin containing a cleavable disulfide linkage. At time 0 or after various times of incubation at 37 °C up to 20 h,
glutathione was added to either the apical or basolateral side to
remove the biotin from cell-surface CPM. Cells that were not treated
with glutathione served as controls for the total amount of remaining
cell-associated biotinylated CPM at a given time point. As expected,
glutathione added to the basolateral side removed the biotin from
essentially all of the labeled CPM at time 0, whereas no biotin was
released from CPM by glutathione added to the apical side (Fig.
7). However, 1 h after
biotinylation, ~30% of the biotinylated CPM was unavailable to
glutathione added to the basolateral side, indicating it had been
endocytosed. Furthermore, at 1 h, a small portion of the CPM that
had been biotinylated on the basolateral side was available to
glutathione added to the apical side and even more at 4 h (Fig.
7). This indicates that the CPM, originally biotinylated on the
basolateral side, had been transcytosed to the apical side. After
20 h, the amount of biotinylated CPM remaining in the cells after
glutathione treatment on either side equaled the total amount of
biotinylated CPM in the control cells, indicating that the small amount
of remaining CPM was intracellular, possibly destined for degradation
(Fig. 7).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
Endocytosis and transcytosis of basolateral
CPM to the apical cell surface. MDCK cell monolayers in 24.5-mm
inserts were selectively biotinylated with sulfo-NHS-SS-biotin on the
basolateral side and incubated at 37 °C for the times indicated. The
biotin label was then selectively removed from apical (+ Apical
GSH) or basolateral (+ Basol. GSH) surface proteins by
extracellular treatment with glutathione on the corresponding side.
Control inserts, treated identically but without the addition of
glutathione, were used to measure the total amount of cellular
biotinylated CPM at each time point (Total (no GSH)). The
cells were solubilized, and CPM was specifically immunoprecipitated.
Precipitated proteins were resolved by SDS-PAGE under nonreducing
conditions and electroblotted onto Immobilon-P. Biotinylated CPM was
detected with streptavidin-horseradish peroxidase and quantitated by
densitometric scanning.
|
|
 |
DISCUSSION |
Sorting of newly synthesized and internalized membrane
proteins in polarized epithelial cells occurs by means of targeting signals present in the proteins, leading to their sequestration in
specific transport vesicles in the trans-Golgi network
(13-15, 30). All GPI-anchored proteins studied to date are apically sorted, and the addition of a GPI anchor to normally non-polarized or
basolateral proteins targets them to the apical surface (9-11, 13, 14,
30). N-Linked carbohydrates on glycoproteins are also
signals for apical targeting (13, 15).
The finding in this study of a relatively non-polarized distribution of
CPM in MDCK cells is quite surprising. This is because CPM contains two
dominant apical targeting signals: N-linked carbohydrate and
a GPI anchor (6, 16, 19). This sorting pattern is unlikely to be
due to an unusual clonal population of cells because the same
distribution was found in cells obtained from the American Type Culture
Collection on two different occasions, and the cells formed tight
junctions as shown by a transepithelial electrical resistance of >400
ohms·cm2 and an apical-to-basolateral
[3H]methoxyinulin diffusion of <2%. The distribution of
alkaline phosphatase and
-glutamyl transpeptidase was predominantly
(81-89%) apical as reported (31). Following a method originally used to show that GPI-anchored proteins are apically sorted (9), five other
GPI-anchored proteins also had a predominant apical distribution. Two
other GPI-anchored proteins had relatively non-polarized distributions,
whereas one appeared to be exclusively basolateral. However, caution
must be used in concluding from these data that other GPI-anchored
proteins have substantial basolateral distributions because this
technique relies only on molecular masses of the bands to identify
proteins on the apical and basolateral membranes. Additional specific
assays would be needed to confirm the distribution of the other
proteins, as we did for CPM. Nevertheless, the distribution of CPM
determined with this technique was consistent with the specific assays used.
It is unlikely that the non-polarized distribution is due to a
non-GPI-anchored form of CPM that is sorted to the basolateral surface.
First, basolateral CPM was readily released by PI-PLC, confirming that
CPM is attached by a GPI anchor on this domain. Second, the C-terminal
sequence of CPM contains all of the required features necessary for GPI
anchoring (16), including a mildly hydrophobic region preceded by a
more polar "hinge region" and the most probable residue at the
attachment site (Ser406, the so-called "
" site) as
well as the preferred residues at the
+ 1 and
+ 2 sites (32).
Although 31% of the total CPM activity in the P3 membrane
fraction was resistant to release by PI-PLC, it is not uncommon for
some portion of GPI-anchored proteins to remain membrane-associated
after PI-PLC treatment (33, 34). Possible explanations include
sequestration into plasma membrane invaginations, localization within a
lipid environment that prevents the PI-PLC access to the anchor
structure, membrane attachment of CPM by a GPI anchor isoform resistant
to cleavage by PI-PLC, and attachment to membranes by an alternative
mechanism. In any case, the higher level of release of CPM from the
basolateral surface by exogenous PI-PLC would indicate that the
resistant fraction derives from apical (not basolateral) membranes. In
this regard, it is also possible that the GPI anchor of CPM is modified during transcytosis to make it resistant to exogenous PI-PLC once it
reaches the apical membrane, although the apparent direct targeting of
CPM to both domains makes this unlikely.
The relatively non-polarized distribution of CPM in these cells results
from the direct sorting of CPM to both the apical and basolateral
domains, although the mechanism of the basolateral targeting of
GPI-anchored CPM remains unclear. All basolateral targeting signals
identified to date reside on the cytoplasmic domain of membrane
proteins and can be classified into three groups (13): 1) a
tyrosine-based motif that has the general consensus sequence
YXX
, where
is a bulky hydrophobic amino acid; 2) a dileucine motif (either Leu-Leu or Leu-Ile); and 3) specific sequences, such as the recently described 23-residue cytoplasmic juxtamembrane sequence on the EGF receptor (35). In some cases, the basolateral targeting motifs also serve as endocytic signals (13). The fact that
CPM has a GPI anchor means that it has no cytoplasmic domain and
therefore cannot have any of the basolateral targeting signals that
have been established for other proteins. The C-terminal sequence of
CPM contains both a potential tyrosine-based (YXX
) basolateral targeting signal as well as a dileucine motif; however, the
Tyr399-Arg400-Asn401-Leu402
sequence is in the extracellular domain, and the
Leu420-Leu421 motif is in the membrane anchor
signal region (16). Neither of these motifs has been shown to function
as a basolateral targeting signal within these contexts. Additionally,
removal of the C-terminal membrane anchor signal and GPI attachment
occur in the endoplasmic reticulum, early after synthesis of the
protein (33). Consequently, the dileucine motif would not be present at
the level of the trans-Golgi where sorting occurs. Retention
of the C-terminal hydrophobic anchor signal sequence cannot be an
explanation for its basolateral localization as our data show that
basolateral CPM is GPI-anchored. In addition, others have shown that
proteins with uncleaved signals for GPI anchoring are retained in the
endoplasmic reticulum and degraded (36, 37). The most logical
explanation is that the extracellular domain of CPM contains a positive
basolateral targeting signal that competes with the glycan and GPI
apical targeting signals, resulting in a relatively non-polarized
distribution. Alternatively, the CPM C-terminal hydrophobic signal
anchor sequence or the GPI anchor itself might possess unique features
that result in basolateral targeting.
The transcytosis of CPM from the basolateral to the apical domain is
consistent with the transcytosis reported for another GPI-anchored
protein, GP2, in MDCK cells (38). The biological role of the
transcytosis pathway is not entirely clear. It may be a way for cells
to transport "missorted" basolateral GPI-anchored proteins to their
"correct" apical location. In the case of CPM, the transcytosis may
indeed contribute to the somewhat higher amount of the enzyme on the
apical domain of MDCK cells at steady state. Nevertheless, the
substantial amount of CPM found on the basolateral domain at steady
state indicates that it is not missorted, but rather is destined there
for some purpose.
The non-polarized distribution of CPM may be of physiological
importance as high levels of kinins have been detected in tubular as
well as interstitial renal fluid (39). Because bradykinin is believed
to act in a paracrine or autocrine fashion, proteolytic cleavage on the
luminal side of tubular epithelium is unlikely to affect bradykinin
activity on the serous side and vice versa. Thus, the non-polarized
distribution of CPM in MDCK cells raises the possibility that it might
separately regulate kinin activity on both the apical and basolateral
sides. The regulation of peptide activity on the basolateral side might
be more significant as other kininases (e.g. neutral
endopeptidase or angiotensin-converting enzyme) are primarily found on
luminal brush border membranes of renal tubules (39, 40).
Immunohistochemical studies have confirmed the presence of bradykinin
B2 receptors on both the apical and basolateral sides of collecting
duct epithelial cells as well as in distal straight tubules and
connecting tubules (41). We found direct evidence for the ability of
CPM to inhibit a bradykinin-mediated B2 receptor response on the
basolateral side of MDCK cells. In these experiments, a specific
inhibitor of CPM potentiated the release of arachidonic acid from MDCK
cells stimulated by bradykinin applied to the basolateral
side.2
Another peptide that is active in the renal system is EGF. Previously,
we found CPM to be the only protease that metabolizes EGF on the
surface of MDCK cells (17). The function of this metabolism is not
clear as the generated metabolite, des-Arg53-EGF, had equal
mitogenic potency on MDCK cells (17). The novel finding that CPM is
present on the basolateral side of MDCK cells co-localizes it with the
basolaterally localized EGF receptor. Whether removal of the C-terminal
Arg could alter other activities or intracellular transport of EGF is
not known. For example, in MDCK cells, 5-30% of the EGF bound to
basolateral receptors is transcytosed to the apical side without the
receptor (21, 42), during which time (90-120 min) it would be expected
that removal of the C-terminal Arg would take place (43, 44). Thus, the initial processing of EGF may serve as a signal or, alternatively, remove a signal for targeting of EGF to different extra- or
intracellular locations, where it could either exhibit additional
activities or be further degraded. Metabolism of EGF by CPM on the
basolateral side may thus have consequences not observed with apically
applied EGF.
 |
ACKNOWLEDGEMENT |
We thank Dr. Richard Minshall (Department of
Pharmacology) for help with the immunohistochemistry.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant DK41431.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Pharmacology
(m/c 868), University of Illinois College of Medicine, 835 S. Wolcott,
Chicago, IL 60612. Tel.: 312-996-9179; Fax: 312-996-1648; E-mail:
rskidgel@uic.edu.
2
G. B. McGwire and R. A. Skidgel,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
CPM, carboxypeptidase M;
GPI, glycosylphosphatidylinositol;
MDCK, Madin-Darby canine kidney;
EGF, epidermal growth factor;
FBS, fetal
bovine serum;
DMEM, Dulbecco's modified Eagle's medium;
HBSS, Hanks'
balanced salt solution;
PBS, phosphate-buffered saline;
sulfo-NHS-biotin, sulfo-N-hydroxysuccinimidobiotin;
dansyl-Ala-Arg, 5-dimethylaminonaphthalene-1-sulfonyl-L-alanyl-L-arginine;
PI-PLC, phosphatidylinositol-specific phospholipase C;
BSA, bovine
serum albumin;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Skidgel, R. A.
(1996)
in
Zinc Metalloproteases in Health and Disease
(Hooper, N. M., ed)
, pp. 241-283, Taylor & Francis Ltd., London
|
| 2.
|
Skidgel, R. A.,
Johnson, A. R.,
and Erdös, E. G.
(1984)
Biochem. Pharmacol.
33,
3471-3478[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Skidgel, R. A.
(1988)
Trends Pharmacol. Sci.
9,
299-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Nagae, A.,
Deddish, P. A.,
Becker, R. P.,
Anderson, C. H.,
Abe, M.,
Tan, F.,
Skidgel, R. A.,
and Erdös, E. G.
(1992)
J. Neurochem.
59,
2201-2212[Medline]
[Order article via Infotrieve]
|
| 5.
|
Nagae, A.,
Abe, M.,
Becker, R. P.,
Deddish, P. A.,
Skidgel, R. A.,
and Erdös, E. G.
(1993)
Am. J. Respir. Cell Mol. Biol.
9,
221-229
|
| 6.
|
Deddish, P. A.,
Skidgel, R. A.,
Kriho, V. B.,
Li, X. Y.,
Becker, R. P.,
and Erdös, E. G.
(1990)
J. Biol. Chem.
265,
15083-15089[Abstract/Free Full Text]
|
| 7.
|
Rodriguez-Boulan, E.,
and Salas, P. J. I.
(1989)
Annu. Rev. Physiol.
51,
741-754[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Cereijido, M.,
Contreras, R. G.,
and Gonzalez-Mariscal, L.
(1989)
Annu. Rev. Physiol.
51,
785-795[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Lisanti, M. P.,
Sargiacomo, M.,
Graeve, L.,
Saltiel, A. R.,
and Rodriguez-Boulan, E.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
9557-9561[Abstract/Free Full Text]
|
| 10.
|
Lisanti, M. P.,
Le Bivic, A.,
Saltiel, A. R.,
and Rodriguez-Boulan, E.
(1990)
J. Membr. Biol.
113,
155-167[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Brown, D. A.,
Crise, B.,
and Rose, J. K.
(1989)
Science
245,
1499-1501[Abstract/Free Full Text]
|
| 12.
|
Lisanti, M. P.,
Caras, I. W.,
Davitz, M. A.,
and Rodriguez-Boulan, E.
(1989)
J. Cell Biol.
109,
2145-2156[Abstract/Free Full Text]
|
| 13.
|
Keller, P.,
and Simons, K.
(1997)
J. Cell Sci.
110,
3001-3009[Abstract]
|
| 14.
|
Rothman, J. E.,
and Wieland, F. T.
(1996)
Science
272,
227-234[Abstract]
|
| 15.
|
Gut, A.,
Kappeler, F.,
Hyka, N.,
Balda, M. S.,
Hauri, H.-P.,
and Matter, K.
(1998)
EMBO J.
17,
1919-1929[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Tan, F.,
Chan, S. J.,
Steiner, D. F.,
Schilling, J. W.,
and Skidgel, R. A.
(1989)
J. Biol. Chem.
264,
13165-13170[Abstract/Free Full Text]
|
| 17.
|
McGwire, G. B.,
and Skidgel, R. A.
(1995)
J. Biol. Chem.
270,
17154-17158[Abstract/Free Full Text]
|
| 18.
|
Skidgel, R. A.,
Davis, R. M.,
and Erdös, E. G.
(1984)
Anal. Biochem.
140,
520-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Skidgel, R. A.,
Davis, R. M.,
and Tan, F.
(1989)
J. Biol. Chem.
264,
2236-2241[Abstract/Free Full Text]
|
| 20.
|
Carretero, O. A.,
and Scicli, A. G.
(1989)
in
Endocrine Mechanisms in Hypertension
(Laragh, J. H.
, Brenner, B. M.
, and Kaplan, N. M., eds)
, pp. 219-239, Raven Press, Ltd., New York
|
| 21.
|
Maratos-Flier, E.,
Kao, C.-Y. Y.,
Verdin, E. M.,
and King, G. L.
(1987)
J. Cell Biol.
105,
1595-1601[Abstract/Free Full Text]
|
| 22.
|
Tan, F.,
Deddish, P. A.,
and Skidgel, R. A.
(1995)
Methods Enzymol.
248,
663-675[Medline]
[Order article via Infotrieve]
|
| 23.
|
Skidgel, R. A.
(1991)
in
Methods in Neurosciences: Peptide Technology
(Conn, P. M., ed), Vol. 6
, pp. 373-385, Academic Press, Inc., Orlando, FL
|
| 24.
|
Orlowski, M.
(1965)
Arch. Immunol. Ther. Exp.
13,
538-541
|
| 25.
|
Naftalin, L.,
Sexton, M.,
Whitaker, J. F.,
and Tracey, D.
(1969)
Clin. Chim. Acta
26,
293-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Le Bivic, A.,
Real, F. X.,
and Rodriguez-Boulan, E.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
9313-9317[Abstract/Free Full Text]
|
| 28.
|
Bretscher, M. S.,
and Lutter, R.
(1988)
EMBO J.
7,
4087-4092[Medline]
[Order article via Infotrieve]
|
| 29.
|
Li, X. Y.,
and Skidgel, R. A.
(1999)
Biochem. Biophys. Res. Commun.
258,
204-210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Simons, K.,
and Wandinger-Ness, A.
(1990)
Cell
62,
207-210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Simons, K.,
and Fuller, S. D.
(1985)
Annu. Rev. Cell Biol.
1,
243-288[CrossRef]
|
| 32.
|
Gerber, L. D.,
Kodukula, K.,
and Udenfriend, S.
(1992)
J. Biol. Chem.
267,
12168-12173[Abstract/Free Full Text]
|
| 33.
|
Low, M. G.
(1987)
Biochem. J.
244,
1-13[Medline]
[Order article via Infotrieve]
|
| 34.
|
Low, M. G.
(1989)
FASEB J.
3,
1600-1608[Abstract]
|
| 35.
|
Hobert, M. E.,
Kil, S. J.,
Medof, M. E.,
and Carlin, C. R.
(1997)
J. Biol. Chem.
272,
32901-32909[Abstract/Free Full Text]
|
| 36.
|
Field, M. C.,
Moran, P.,
Li, W.,
Keller, G.-A.,
and Caras, I. W.
(1994)
J. Biol. Chem.
269,
10830-10837[Abstract/Free Full Text]
|
| 37.
|
Delahunty, M. D.,
Stafford, F. J.,
Yuan, L. C.,
Shaz, D.,
and Bonifacino, J. S.
(1993)
J. Biol. Chem.
268,
12017-12027[Abstract/Free Full Text]
|
| 38.
|
Fritz, B. A.,
and Lowe, A. W.
(1996)
Am. J. Physiol.
270,
G176-G183[Abstract/Free Full Text]
|
| 39.
|
Carretero, O. A.,
and Scicli, A. G.
(1995)
in
Hypertension: Pathophysiology, Diagnosis, and Management
(Laragh, J. H.
, and Brenner, B. M., eds), 2nd Ed.
, pp. 983-999, Raven Press, Ltd., New York
|
| 40.
|
Skidgel, R. A.,
and Erdös, E. G.
(1993)
in
The Renin-Angiotensin System
(Robertson, J. I. S.
, and Nicholls, M. G., eds), Vol. 1
, pp. 10.1-10.10, Gower Medical Publishing, London
|
| 41.
|
Figueroa, C. D.,
Gonzalez, C. B.,
Grigoriev, S.,
Abd Alla, S.,
Maasemann, M.,
Jarnagin, K.,
and Müller-Esterl, W.
(1995)
J. Histochem. Cytochem.
43,
137-148[Abstract]
|
| 42.
|
Brandli, A. W.,
Adamson, E. D.,
and Simons, K.
(1991)
J. Biol. Chem.
266,
8560-8566[Abstract/Free Full Text]
|
| 43.
|
Planck, S. R.,
Finch, J. S.,
and Magun, B. E.
(1984)
J. Biol. Chem.
259,
3053-3057[Abstract/Free Full Text]
|
| 44.
|
Schaudies, R. P.,
and Savage, C. R., Jr.
(1986)
Endocrinology
118,
875-882[Abstract]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Paladino, D. Sarnataro, R. Pillich, S. Tivodar, L. Nitsch, and C. Zurzolo
Protein oligomerization modulates raft partitioning and apical sorting of GPI-anchored proteins
J. Cell Biol.,
November 22, 2004;
167(4):
699 - 709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. M. Eckhardt, L. Cai, B. Sun, N. R. Webb, and D. R. van der Westhuyzen
High Density Lipoprotein Uptake by Scavenger Receptor SR-BII
J. Biol. Chem.,
April 2, 2004;
279(14):
14372 - 14381.
[Abstract]
[Full Text]
[PDF]
|
 |
|